<DOC>
	<DOCNO>NCT01682564</DOCNO>
	<brief_summary>To compare evaluate efficacy safety Candemore tab . versus Atacand tab . blood pressure patient hypertension diagnose congestive heart failure</brief_summary>
	<brief_title>To Evaluate Efficacy Safety Blood Pressure In Patients With Hypertension Diagnosed Congestive Heart Failure</brief_title>
	<detailed_description>This open label , randomize , active drug comparative , Parallel group , Multi-center , phase IV study . Patients receive candemore tablet atacand tablet . Initial dose 4mg/day 8mg/day . Every 2 week , patient take double dose patient blood pressure measure SBP ≥ 100mmHg DBP &gt; 60mmHg . Maximum dose 16mg/day .</detailed_description>
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Candesartan cilexetil</mesh_term>
	<mesh_term>Candesartan</mesh_term>
	<criteria>willing able provide write informed consent age 20 year old patient congestive heart failure , take treatment medicine NYHA grade II~III patient hypertension , take treatment medicine SBP ≥ 140mmHg DBP ≥ 90mmHg screening visit Known suspect secondary hypertension ( ex . aortic coactation , primary hyperaldosteronism , renal artery stenosis , pheochromocytoma , cushing syndrome , polycystic renal disease ) blood creatinine level ≥ 2.5mg/dl blood potassium level &gt; 5.5mEq/L blood SGOT , SGPT level ≥ maximum normal range X3 patient sever hepatic dysfunction , cholestasis pregnant breastfeeding premenopausal woman use adequate contraception patient history hypersensitivity taboo investigational product patient lactose intolerance Lapp lactase deficiency glucodegalactose malabsorption administration study drug within 1 month prior screen history ischemic heart disease ( ex . angina pectoris , myocardial infarction ) within last 3 month investigator 's judgement</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2015</verification_date>
	<keyword>Candemore</keyword>
	<keyword>Atacand</keyword>
	<keyword>Candesartan cilexetil</keyword>
	<keyword>Primary Hypertension</keyword>
	<keyword>Congestive Hypertension</keyword>
</DOC>